Syngene International Ltd. News and Updates

Keep track of all breaking news on Syngene International Ltd. from all sources in a single place.

Load latest

27 Jul 2023

717.45

-0.10%

Syngene International Results Earnings Call for Q1FY24

Conference Call with Syngene International Management and Analysts on Q1FY24 Performance and Outlook. Listen to the full earnings transcript.

audio

Syngene International Ltd.

27 Jul 2023

717.45

-0.10%

Syngene International gains 6% on healthy Q1 numbers

Moneycontrol

The firm's consolidated profit was up 26 percent year-on-year increase at Rs 93 crore, while revenue from operations rose 25.4 percent to Rs 808.1 crore in the June quarter

Syngene International Ltd. is trading below its 50 day SMA of 720.6

Syngene International Q1FY24: Net profit up 26%, revenue surges 25.4%

Moneycontrol | 26 Jul 2023 2 more

Syngene International Ltd.

26 Jul 2023

717.45

-0.10%

to see Rapid results content

Syngene International Ltd.

05 Jul 2023

717.45

-0.10%

Syngene to acquire Unit 3 biologics manufacturing site for gross value of 702 cr

Business Line

The facility is being repurposed to manufacture monoclonal antibodies; Syngene to further invest up to 100 crore to repurpose and revalidate the facility

Number of FII/FPI investors increased from 337 to 359 in Dec 2024 qtr.

Syngene to acquire plant from Stelis Biopharma for Rs 702 crore

Moneycontrol | 05 Jul 2023

Syngene International Ltd.

05 May 2023

717.45

-0.10%

CRO market still very much untapped in India: Cyndrella Carvalho

Economic Times

Indian CROs and CDMOs are attracting a lot of attention as companies, such as Syngene, Suven, and Divis, create long-term relationships with top pharma organisations. According to Cyndrella Carvalho of JM Financial, India still has a vital untapped CRO market, and with its large and diverse population, it offers enormous potential for growth in medical research. The market is so tight that even larger unlisted businesses, such as India's Aragen, are making a name for themselves.

Syngene Internationa.. has an average target of 1030.00 from 1 broker.

Syngene International Ltd.

02 May 2023, 08:56AM

717.45

-0.10%

Big Movers on D-St: What should investors do with Syngene International, REC and EIH?

Economic Times

Sectorally, buying was seen in telecom, capital goods, utilities, public sector and power stocks while selling was seen in consumer durables. Stocks that were in focus include names like Syngene International which rose more than 4%, EIH rallied nearly 10% and REC closed with gains of over 5% on Friday.

Syngene International Ltd. is trading below its 50 day SMA of 720.6

Syngene International Ltd.

28 Apr 2023

717.45

-0.10%

Revenue will grow in high teens' in FY24: Syngene CEO

livemint

It was the strongest quarter ever led by the combination of the trends that we saw during the yeargood progress in research services, discovery services and dedicated centres, improved operating performance in our development business and strong uptick in manufacturing services